Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2021-09-10 Regulatory Filings
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
110年年報及股東會資料 — 2021_1720_20210618FE1.pdf
Regulatory Filings
2021-09-10 Chinese
110年年報及股東會資料 — 2021_1720_20210618F14.pdf
Governance Information Classification · 95% confidence The document is a detailed procedural manual titled '取得或處分資產處理程序' (Procedures for Acquisition or Disposal of Assets) for a company, outlining internal control processes, evaluation methods, authorization limits, and compliance with relevant laws and regulations. It includes sections on asset scope, valuation reports, handling related party transactions, derivative transactions, merger and acquisition procedures, disclosure requirements, and penalties for non-compliance. There is no indication that this is a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for asset transactions and compliance. Therefore, it fits best under Governance Information (CGR). The document length and content confirm it is not a brief announcement or certification but a substantive governance report.
2021-09-10 Chinese
110年年報及股東會資料 — 2021_1720_20210618F05.pdf
AGM Information Classification · 100% confidence The document is a detailed record of an Annual General Meeting (AGM) of 生達化學製藥股份有限公司 held in the year 110 (Taiwan calendar), including attendance, reports, resolutions, voting results, and election of directors. It contains extensive discussion of the company's 109 fiscal year business report, financial statements, dividend distribution, and other corporate governance matters. The document also includes audit reports and financial statements as attachments, but these are part of the AGM materials. The presence of detailed voting results and discussions on various agenda items confirms this is the official minutes and materials of the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2021-09-10 Chinese
110年年報及股東會資料 — 2021_1720_20210618F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains detailed information about the top ten shareholders, their shareholdings, and their relationships to each other, including family ties and related parties. This type of disclosure is typical of a Major Shareholding Notification, which reports changes or details about significant share ownership levels. The document does not contain financial statements, management discussion, or other report types. It is not an announcement of a report but a direct disclosure of shareholding information.
2021-09-10 Chinese
110年年報及股東會資料 — 2020_1720_20210618F04.pdf
Annual Report Classification · 100% confidence The document contains extensive detailed information typical of a comprehensive annual report, including sections such as shareholder reports, company overview, governance report, capital raising activities, operational overview, financial summary with multiple years of financial data, management discussion and analysis, and risk factors. It includes audited financial statements and auditor information, detailed company history, governance details, and strategic outlook. The length is substantial (15,000 characters), and the content is consistent with a full annual report rather than a brief announcement or presentation. There is no indication that this is merely an announcement of a report or a certification document. Therefore, the document is best classified as an Annual Report (10-K). FY 2020
2021-09-10 Chinese
110年年報及股東會資料 — 2021_1720_20210618FE2.pdf
AGM Information Classification · 100% confidence The document is titled 'Handbook for the 2021 Annual Meeting of Shareholders' and includes detailed agenda items for the Annual General Meeting (AGM) of Standard Chem. & Pharm. Co., Ltd. It contains meeting procedures, agenda, report items, matters proposed for ratification, and election resolutions. The content includes business reports, financial statements, auditor reports, dividend distribution, and proposals for shareholder approval. The document is clearly the materials and agenda prepared for the AGM, not the full annual report or financial statements themselves. It is a presentation and reference material for the shareholders' meeting, consistent with the definition of AGM Information (AGM-R). The document length is substantial (15,000 characters), indicating it is not a brief announcement or notice but the actual meeting handbook. Therefore, the correct classification is AGM Information (AGM-R).
2021-09-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.